IFNG and cancer: In accordance with a previous report (39), recombinant IFN-γ synergized with Pam3CSK4 in inducing NO production and BMDM-mediated growth inhibition of cancer cells in a dose-dependent manner starting from the lowest IFN-γ concentration, 0.04 ng/mL (Figures 4A,B).